The controversy surrounding the degree of carcinogenicity of different asbestos types, especially chrysotile versus amphibole asbestos, continues to influence scientific and regulatory discussions.

This classification is used when there is limited or inadequate evidence of "carcinogenicity in humans" and there is either more evidence showing they cause cancer in animals, or strong evidence ...

Proposed Changes to Pharmaceutical Carcinogenicity Testing May Shrink Time-to-Market for New Drugs Prior to obtaining regulatory approval for use in humans, novel pharmaceutical drugs require ...

There is “limited evidence” for carcinogenicity in humans, from non-sugar sweetener aspartame, said an assessment of its health impact report released by the International Agency for Research ...

Paul Pharoah, PhD, DPH, professor of Cancer Epidemiology, Cedars-Sinai Medical Center, London, United Kingdom, found the evidence for the carcinogenicity of talc in humas "extremely weak." ...

More information: Jan C. Klapwijk et al, Improving the Assessment of Risk Factors Relevant to Potential Carcinogenicity of Gene Therapies: A Consensus Article, Human Gene Therapy (2024). DOI: 10. ...

This page lists all known medications that could potentially lead to 'Carcinogenicity' as a side effect. It's important to note that mild side effects are quite common with medications.

A significant part of the upside can be attributed to the dermal carcinogenicity (CARC) waiver granted by the FDA for TMBR’s topical isotretinoin product, TMB-001. This product is in a late ...

Can they actually cause health problems in the long run? Maybe, if new research into the carcinogenicity of common 3D printing plastics pans out. To do this, they generated particulates by heating ...